CHOUA VANG: Open Payments
NPI 1528805678 · OVERLAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,148 in 68 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $18 · 2025 $1,148
Food & beverage: $1,148
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 21 | $362 |
| Vanda Pharmaceuticals Inc. | 21 | $264 |
| Otsuka America Pharmaceutical, Inc. | 5 | $140 |
| E.R. Squibb & Sons, L.L.C. | 8 | $137 |
| Lundbeck LLC | 4 | $80 |
| Axsome Therapeutics, Inc. | 4 | $59 |
| Neurocrine BioSciences, Inc. | 2 | $38 |
| Supernus Pharmaceuticals, Inc. | 1 | $33 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
Products named: ARISTADA, HETLIOZ, REXULTI, COBENFY, Auvelity, INGREZZA, Qelbree, LYBALVI.
Industry payments across KS — which companies pay providers there.
